Development of DARPin T cell engagers for specific targeting of tumor-associated HLA/peptide complexes
The balance between affinity and specificity in T cell receptor (TCR)-dependent targeting of HLA-restricted tumor-associated antigens presents a significant challenge for immunotherapy development. T cell engagers that circumvent these limitations are therefore of particular interest. We established a process to generate bispecific designed ankyrin repeat proteins (DARPins) that simultaneously target HLA-I/peptide complexes and CD3e. These high-affinity T cell engagers elicited CD8<sup>+</sup> T cell activation against tumor targets with strong peptide specificity, as confirmed by X-scanning mutagenesis and functional killing assays. A cryo-EM structure of the ternary DARPin/HLA-A∗0201/NY-ESO1<sub>157-165</sub> complex revealed a rigid, concave DARPin surface spanning the full length of the peptide-binding cleft, contacting both α-helices and the peptide. The present findings reveal promising immuno-oncotherapeutic approaches and demonstrate the feasibility of rapidly developing DARPins with high affinity and specificity for HLA/peptide targets, which can be readily combined with a new generation of anti-CD3e-specific DARPins.
Authors
- Sandra Bruckmaier
- Marcel Walser
- Denis Villemagne (ORCID: https://orcid.org/0000-0002-4465-364X)
- Tim Schulte (ORCID: https://orcid.org/0000-0002-7322-8933)
- Stefanie Fischer (ORCID: https://orcid.org/0000-0001-9609-3640)
- Nicole Pina
- Adnane Achour (ORCID: https://orcid.org/0000-0003-0432-710X)
- Filip Radom
- Evren Alici (ORCID: https://orcid.org/0000-0001-5307-6648)
- Nadir Kadri (ORCID: https://orcid.org/0000-0003-2623-4094)
- Xiao Han
- Tanja Hospodarsch
- Tatyana Sandalova (ORCID: https://orcid.org/0000-0002-7694-6420)
- Benedict J. Chambers (ORCID: https://orcid.org/0000-0003-0437-8441)
- Andreas Cornelius
- María Emilia Paladino
- Marta Carroni (ORCID: https://orcid.org/0000-0002-7697-6427)
- Sandra Müller (ORCID: https://orcid.org/0000-0003-4269-4437)
- Victor Levitsky (ORCID: https://orcid.org/0000-0003-3417-0545)
- R. Sun (ORCID: https://orcid.org/0009-0009-2563-7706)
- Karin Wallden
- Hans‐Gustaf Ljunggren
- Tom Resink (ORCID: https://orcid.org/0000-0002-2851-1684)
- Natalia Venetz-Arenas
Institutions
- Karolinska University Hospital (SE)
- Stockholm University (SE)
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
- Molecular Partners (Switzerland) (CH)
- Integrated Cardio Metabolic Centre (SE)
Publication Details
- Journal
- iScience
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.isci.2025.113926
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00